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SUMMARY
Testicular hyperechogenic foci (THF) are associated with Klinefelter’s syndrome, cryptorchidism, infertility, and testicular germ
cell neoplasia. The aims of the study were to evaluate THF in relation to etiology of azoospermia and to Sertoli cell dysfunction. The
structures inside the scrotum of consecutive non-vasectomized, azoospermic were examined by ultrasonography, and hormone
(FSH, LH, testosterone, and prolactin), and genetic analyses (karyotype, Y microdeletions, and CFTR mutations) were performed. At
testicular ultrasonography, patients were graduated into: pronounced THF (>7 THF per transducer field), distributed universally
(uTHF) or collected in plaques (pTHF), borderline THF (bTHF; 3–7 THF per transducer field), or no THF (<3 THF per transducer
field). Diagnostic testicular biopsy was taken open or with TruCut needle (14G). THF status was sufficiently described in 382 of 449
potential participants, and testicular histology was available in 300 cases. Presence of ultrasonographically detectable THF was com-
pared to presence of testicular microlithiasis (TM) detected histologically. Sertoli cell dysfunction was investigated in a subgroup
using a three-stage immunoperoxidase technique for detection of cytokeratin-18 (CK-18). The prevalence of THF was 13.4%. uTHF
was found in 11 men (2.9%), the pattern was bilateral in four while other four had bTHF in the other testis. pTHF was detected in
eight cases (2.1%), and except for one case with Klinefelter’s syndrome, pTHF was in all cases occurring unilaterally. bTHF was
detected in 32 cases (8.4%), bilaterally in 17 (53%). Pronounced THF was significantly associated with testicular malignancy. CK-18
was detected in more azoospermic men with sperm production in ≤50% seminiferous tubules than in azoospermic men with sper-
matogenesis in ≥90% of seminiferous tubules and normal controls (p < 0.05). Unfortunately, TM detected histologically was not
detected in any patient expressing THF, and neither THF nor TM was detected in any of the patients examined for CK-18. Sertoli cell
dysfunction was not associated with testicular microlithiasis or hyperechogenic foci.
INTRODUCTION
In 1987, Doherty et al. (1987) described a 23-year-old man,
who at age 10 had an orchiopexy for cryptorchidism. By ultra-
sonography, a pattern of innumerable tiny bright echoes (‘white
spots’) diffusely and uniformly scattered throughout the testis
tissue was found. The atrophic and previously cryptorchid testis
was removed by an inguinal orchiectomy. By histological evalua-
tion, no tumor was found, but calcific concretions were present
in 30–40% of the seminiferous tubules, and the histologic diag-
nosis was testicular microlithiasis (TM).
As this report was published, several studies evaluating the
prevalence of men with such white spots (testicular hypere-
chogenic foci = THF) in the testis tissue and its association with
pathological, andrological conditions, have been performed. The
evidence documenting that THF in all cases represents TM
seems insufficient, and presence of such white spots in the testis
in this study is termed THF, although usually termed TM in the
literature. Usually >5 or ≥5 THF 1–3 mm of size in one trans-
ducer field (Backus et al., 1994 & Peterson et al., 2001) or in one
testis (Goede et al., 2009, 2010) is considered pathological. The
limit of five THF per transducer field has been used uncritically
as the limit for abnormally high numbers.
Histologically detected microliths were initially described by
Nistal et al. (1979). They are located within the seminiferous
tubules and consist of a core of hydroxyapatite (Smith et al.,
1999). This core is surrounded by concentric layers of collagen
fibers surrounded by material rich in glycogen (DeJong et al.,
2004). Vegni-Talluri et al. (1980) has suggested that TM
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originates from degenerated intratubular cells not phagocyted
by the Sertoli cells. Thus, it may be hypothesized that the back-
ground of TM could be defective spermatogenesis or dysfunc-
tion of the Sertoli cells (Vegni-Talluri et al., 1980).
Using the definition of >5 THF per transducer field, preva-
lences of many abnormal THF in healthy young men have been
found to be 2.4–5.6% (Peterson et al., 2001 & Serter et al., 2006)
depending on ethnicity and geographical origin of USA, showing
the highest prevalence in black men and men from southeastern
states. In the majority of cases, THF occurs bilaterally (Peterson
et al., 2001; DeGouveia Brazao et al., 2004; Serter et al., 2006 &
Cooper et al., 2014).
Several studies have demonstrated or suggested an association
between THF and pathological andrological conditions such as
Klinefelter’s syndrome (KS) (Martinez-Valls et al., 2003 & Fedder
et al., 2015), cryptorchidism (Nistal et al., 1979; Riebel et al.,
2000 & Goede et al., 2010), and infertility (Aizenstein et al., 1998
& von Eckardstein et al., 2001). Furthermore, presence of THF
has been associated with (increased risk of) intratubular germ
cell neoplasia (IGCN) (van Casteren et al., 2009).
However, in almost all studies on THF (usually termed TM), the
diagnosis is based solely on ultrasonographic detection of white
spots in the testicles (van Casteren et al., 2009 & Goede & Hack,
2012). Histological examination is with few exceptions limited to
evaluation of spermatogenesis and presence of testicular germ
cell neoplasia (TGCN) without description of histological detect-
able microliths in the testis tissue. In addition to a few case stud-
ies, only Holm et al. (2003) evaluated ultrasonographically
detectable THF and histologically detectable TM on the same
material. However, it is not evident how often TM was found in
patients with THF (Holm et al., 2003). As THF might represent
other conditions than TM as seen after, for example, operations
on the testicles (Fedder et al., 2016), examination of the associa-
tions between THF and TM in larger studies is greatly required.
Published data represent a huge variation in numbers and dis-
tributions of THF, and the significance of a low number of THF
(borderline cases) has yet to be discovered. It seems highly rele-
vant to evaluate the prevalence of THF in a cohort of men with
azoospermia, the most manifested condition of male infertility.
Azoospermia has an extensive variety of etiologies (Fedder et al.,
2004). In a previous study, a probable cause of azoospermia
could be identified in 78% of 100 azoospermic, consecutively
included men (Fedder et al., 2004). Therefore, it is relevant to
look for potential associations of THF with specific subgroups of
azoospermia.
To answer the hypothesis that immature or dedifferentiated
Sertoli cells might cause TM, we included results from a minor
series of consecutive participants among these azoospermic
men examined for the presence of the Sertoli cell differentiation
marker cytokeratin-18 (CK-18) by immunohistochemistry
(Franke et al., 2004). An association between CK-18 and THF/
TM might contribute to explain the mechanisms in THF/TM for-
mation. Expression of CK-18, which in normal men is found only
in fetal Sertoli cells, is frequently found in Sertoli cells from adult
men with cryptorchidism or TGCN (Rogatsch et al., 1996). Such
men also have an increased frequency of THF.
The aims of the study were to evaluate:
• Whether presence of THF correlated with histological
detection of TM,
• The possible associations of THF patterns and intensities with
different categories of azoospermic men, and
• The possible associations between presence of cytokeratin-18
(CK-18) and ultrasonographically detected THF and histologi-
cally detected TM.
MATERIALS ANDMETHODS
The diagnosis azoospermia was based on examination of at
least two ejaculates including centrifugation and microscopic
evaluation of the pellet. Since 1997, we have performed an exami-
nation program as described by Fedder et al. (2004) for all men
referred with azoospermia on a non-vasectomy basis. The pro-
gram was initiated in the Fertility Clinic, Horsens-Braedstrup
Hospital, and from May 2011 in an extended version carried on in
the Centre of Andrology / Fertility Clinic, Odense University
Hospital. All clinical examinations, including ultrasonography and
testicular biopsy, were performed by the same specialist.
All included men were examined clinically, including body
composition and body proportions, hair distribution, and scrotal
examination. Basis hormone analyses included: FSH, LH, testos-
terone, TSH, and prolactin, and genetic analyses included kary-
otype, Y microdeletions, and CFTR mutations (Fedder et al.,
2004). Two specific sequence-tagged sites (STSs) were used for
detection of deletions in each of the AZFa, AZFb, and AZFc
regions. Furthermore, the patients were examined for deletion in
the SRY region. Routinely, the patients were examined for 32
CFTR mutations in the exons and for mutations in IVS8 5/7/9T
(intron 8).
The program was carefully performed with the purpose to sub-
classify the azoospermic men into different etiological cate-
gories. Although this program does not represent a prospective
study with testicular ultrasonography as primary outcome, tes-
ticular ultrasonography was systematically performed as part of
the program.
Ultrasonography of the scrotum
Ultrasonographic investigation of the scrotal contents was
performed using Siemens equipment, including 7.5 MHz linear
transducers. Testicular volumes were calculated as: p/6 9 testis
length 9 (testis diameter)2 (Behre et al., 1989), and the
echogenicity of the testicular tissue was evaluated.
More than seven THF in one transducer field is in this study
considered as clearly pathological. However, THF patterns show a
considerable variation according to the amount as well as the dis-
tribution of THF. Testicles with 3–7 THF were considered as
belonging to a ‘borderline’ subgroup (bTHF). Men with pro-
nounced THF were subdivided into two subgroups, considering
men with universally distributed THF (uTHF) as one subgroup and
men with THF located in ‘plaques’ (pTHF) as another subgroup.
Biopsy procedure
All azoospermic men without KS and hypogonadotropic
hypogonadism were offered testicular biopsy, unless the couples
had in advance decided to use donor semen (and the ultrasonog-
raphy showed no THF).
Following application of lidocaine, 200–400 mg, into the upper
scrotum on each side of the spermatic cord, the testicular biopsy
was taken either as a traditional open biopsy detaching a speci-
men of testicular tissue bulging out through an incision on the
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Tunica albuginea (Fedder et al., 2004) or more often as one to
three TruCut biopsies (Ch 14) (Fedder, 2011). The first 120 men
had open biopsies, while the remaining men had TruCut biop-
sies. If living spermatozoa were found in the first testicle, and
the other testicle appeared normal without THF, testicular
biopsy was only performed unilaterally. In the remaining cases,
testicular biopsy was performed bilaterally provided the man
had two testicles. Each TruCut biopsy has a volume of 24 mm3
(Fedder, 2011). With each technique, areas with at least 100 sem-
iniferous tubule sections were usually available, and therefore,
the histological diagnosis was representative and independent of
the biopsy technique chosen.
Immunohistochemistry
In a prospective substudy including a consecutive series of 33
azoospermic men also included in the main study, and 7 normal
controls undergoing vasectomy, the maturity of the Sertoli cells
was determined based on detection of CK-18 by immunohisto-
chemistry. A piece of the diagnostic testicular testis biopsy was
snap-frozen in liquid nitrogen.
Cryostat microtome sections, 8-lm thick, were cut and stored
at 70 °C until fixed in paraformaldehyde, 2% (5 min) and
stained using a three-stage immunoperoxidase technique. The
sections were preincubated with 1% BSA in COON’s for 1 h, and
endogenous biotin was blocked using Vector SP2001. CK-18 was
detected by a mouse monoclonal antibody (Santa Cruz Biotech-
nology, cat#sc-6259) (1 h, room temp). A mouse immunoglobu-
lin G1 (Pharmingen 33811A) was used as control. Thereafter, the
sections were incubated with biotinylated donkey anti-mouse
antibody (Jackson, 715-066-150, 1 : 400, 45 min). Horseradish
peroxidise–avidin biotin complex (HRP-sABC, DAKO, K 0377)
was used for identification of the antigen–antibody binding sites,
and the peroxidase activity was visualized using a 0.05% solution
of diaminobenzidine tetrahydrochloride (DAB, Sigma D-5637,
15 min). Counterstaining was performed with Mayer’s hema-
toxylin (5 min). The stained sections were mounted with Aqua-
mount BDH 362262H and read blindly.
COON’s buffer with 1% BSA was used as blocking and washing
buffer up to and including the secondary antibody layer. TRIS
0.005 M, pH 7.6 was used for the third layer and the substrate
including wash before application of these two layers. Following
substrate and hematoxylin application, tap water was used for
wash.
Statistics
Associations between THF patterns and testicular neoplasia
and between CK-18 and spermatogenesis were evaluated using
Fisher’s exact test.
Approvals
The study was approved by the Danish Data Protection Agency
(15/17627) and the Danish Health and Medicine Authority (3-
3013-1088/1). The prospective immunohistochemical substudy
with CK-18 was further approved by the Data Protection Agency
and the local Scientific Ethics Committee (Vejle og Fyns Amter;
J.nr. 97/258 PMC).
RESULTS
During the period November 1st, 1997–April 30th, 2015, 449
non-vasectomized, azoospermic men were referred for
examination. Several men referred with azoospermia were diag-
nosed as having cryptozoospermia (Ben-Ami et al., 2013) and
were not included. Although all azoospermic men went through
the full evaluation program, the presence of small testicular
hyperechogenic foci was only sufficiently described in 382
patients (33  6 years of age; Table 1), and the remaining 67
therefore were excluded for further analysis. Only the 382 men
with a known THF status were included in the further study.
As shown in Fig. 1, normal testicles often show a wedge-
shaped hyperechogenic area representing the Mediastinum tes-
tis. uTHF (Fig. 2) was found in 11 men (2.9%). In four of these
(36%), uTHF was found bilaterally. In four cases, including three
with KS, bTHF was detected in the contralateral testis. The
author had the opportunity to examine one of the men with
uTHF when he was 42 years old and again when he was 50 years
old. The THF patterns were very similar suggesting that the con-
dition may remain unchanged over time (Fig. 3). A testicular
TruCut biopsy taken after the last ultrasonography showed no
signs of (pre-)malignancy. pTHF (Fig. 4) was detected in eight
cases (2.1%), and except for one KS man, the condition was in all
cases unilaterally. bTHF was detected in 32 cases (8.4%), bilater-
ally in 17 (53%). Unilateral bTHF was found in a further four
cases with uTHF in the other testis, and these cases were catego-
rized as having uTHF. Microcalcifications were not detected his-
tologically in testicular biopsies from any of the patients with
ultrasonographically detected THF.
A frequent overlapping between the most relevant etiological
groups was found, for example, 10 (23%) of the 44 men with KS
and four (20%) of the men with Y microdeletions had a history of
cryptorchidism. Of 40 men with CFTR mutations, four had THF.
However, three of these four men had additional etiological fac-
tors, two had cryptorchidism and one had an ejaculatory disor-
der (Table 1).
Some diagnoses, for example, cryptorchidism, are categorized
as secondary diagnosis in men with KS or Y microdeletions.
When cryptorchidism was the only pathological andrological
finding, this was categorized as primary diagnosis in Table 1.
In azoospermic men with competing diagnoses, diagnoses
causing primary testicular defects were ranked higher (more
important) than diagnoses causing azoospermia on an obstruc-
tive basis.
Five of the KS men had pronounced THF, three (7%) had
uTHF and two (5%) had pTHF, while 14 (32%) showed bTHF. Of
101 men with a history of cryptorchidism, two (2%) had uTHF,
two (2%) pTHF, and 14 (14%) bTHF. The power of the study is
not strong enough to meaningfully compare different subgroups
of men with histories of cryptorchidism. All four men with pro-
nounced THF were found among 73 (64 + 9) men operated on
for or having persisting cryptorchidism.
bTHF occurred with a high prevalence in men with KS who
all—as expected—had small testicular volumes. The prevalences
of uTHF and pTHF were low, and as the conditions were dis-
tributed on different etiological categories, the power of this
study cannot bear an evaluation of the association between THF
and testicular volume.
Considering the association between THF (u+p+b) and
impaired spermatogenesis of any kind (Sertoli cell only, matura-
tion stop, or testicular atrophy), the sensitivity was 14.3% and
the specificity 98.6%, showing that almost no men with normal
testicular histology had THF. The positive predictive value of
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THF (u+p+b) to detect impaired spermatogenesis was 97.1% and
the negative predictive value was 25.6%, showing that men with
THF usually had impaired spermatogenesis in this study.
One of 266 men without THF had IGCN. Compared hereto the
frequencies of TGCN and IGCN in men with uTHF was one of
six (p = 0.04), in men with pTHF one of seven (p = 0.05), and in
men with bTHF one of 21 (p = 0.14) (Table 2). In this study, pos-
itive and negative predictive values of THF to predict germ cell
neoplasia (GCN) were 8.8% and 99.6%, respectively, suggesting
that GCN seldom occurs in men without THF.
In one particular case, a 19-year-old man with uTHF and only
one detectable testis, IGCN was found (Fig. 2). As a boy, he was
extensively examined, including laparoscopy, but the testicle
was not found. Because the young man had azoospermia, it was
not possible to cryopreserve the ejaculated spermatozoa prior to
operation. However, a large number of living and morphologi-
cally normal spermatozoa were isolated from foci with sperm
production in the present testis. These spermatozoa were cryop-
reserved before radiation therapy.
In the series of 33 azoospermic men and seven normal con-
trols examined for CK-18 (Fig. 5) and included in this project,
CK-18 was detected by immunohistochemistry in 10–100% of
seminiferous tubules in five of 13 men without sperm produc-
tion and in 20–90% of tubules in five of eight men with sperm
production in 5–50% of tubules. This stands in contrast to only
two of 12 men (CK-18 in 5% and 50% of tubules) with sperm
production in ≥90% of tubules and in 0 of the seven controls
(p < 0.05). However, none of the 33 azoospermic men exam-
ined in this substudy showed THF at ultrasonography or TM at
histological examination.
DISCUSSION
In this retrospective study of an unselected cohort of 382
non-vasectomized, azoospermic men carefully examined by
testicular ultrasonography during a systematic examination
program, the prevalence of THF was 13.4%: pronounced in 5%
and borderline in 8.4%. The prevalence of THF was particu-
larly high in men with KS or a history of cryptorchidism.
Figure 1 In normal testicles hyperechogenic,
wedge-shaped areas representing the Mediasti-
num testis are seen by ultrasonographic exami-
nation. [Colour figure can be viewed at
wileyonlinelibrary.com].
Table 1 Levels of testicular hyperechogenic foci (THF) distributed according to etiological subgroups of azoospermia
Primary diagnosis Secondary diagnosis <3 THF 3–7 THF borderline >7 THF, plaques >7 THF, universal
47, XXY (Klinefelter) None 19 10 2 1
Crypt., persisting 1 – – 1
Crypt., requiring operation 1 2 – 1
Crypt., requiring hormone treatment 1 1 – –
Crypt. with spontaneous testicular descent 1 1 – –
CFTR mutations 2 – – –
Y microdeletion None 12 3 – –
Crypt. requiring operation 1 – – –
Crypt. with spontaneous testicular descent 3 – – –
CFTR mutations 1 – – –
Crypt., persisting None 4 1 – –
CFTR mutations 1 – – –
Ejaculatory disorder 1 – – –
Crypt. requiring operation None 42 6 1 –
CFTR mutations 5 – 1 –
Hypogonadotropic hypogonadism 1 – – –
History of orchitis or genital tract infection 1 – – –
Crypt. treated with hormones None 1 1 – –
CFTR mutations 1 – – –
Hypogonadotropic hypogonadism 1 – – –
Crypt. with spontaneous testicular descent None 13 1 – –
CFTR mutations 1 1 – –
CFTR mutations None 23 – 1 –
History of orchitis or genital tract infection 2 – – 1
History of orchitis or genital tract infection None 14 1 – 1
Hypogonadotropic hypogonadism None 2 1 – –
Ejaculatory disorders None 11 – 1 –
Unknown etiology 165 3 2 6
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Remarkably, a major proportion of men with KS (14 of 44,
~32%) showed bTHF.
It may be suggested that THF may originate from degenerated
intratubular germ cells not phagocytized by Sertoli cells the
same way as TM as supposed by Vegni-Talluri et al. (1980).
However, not all hyperechogenic areas represent calcifications.
Thus, the Mediastinum testis, consisting of connective tissue,
vessels, veins, and nerves appear hyperechogenic, although not
containing calcifications. Furthermore, microcalcifications were
not detected histologically in testicular biopsies from any of the
patients with ultrasonographically THF. Possible explanations
for this might be that tissue sections for histological examination
were cut between the THF/TM, or that microliths were lost dur-
ing the fixing and staining procedures preceding histological
examination. However, it seems unlikely that THF could in all
case have been ‘hidden’, and as microliths were conserved at
histological examination in ram testicles prepared in a way simi-
lar to the one used in this study (Fedder et al., 2016), it seems
unlikely that the microliths should have been perished during
preparation. Furthermore, cutting of testicular tissue with
microcalcifications often cause foldings of the tissue sections
(Fedder et al., 2016), which was not described in any prep in this
study. Thus, THF not necessarily represent TM,
THF patterns occurring in stripes or beams (Fig. 3) might rep-
resent the testicular septae consisting of stripes of connective
tissue with small vessels, veins, and nerves and dividing the tes-
tis parenchyma into testicular lobules.
It is a question why THF occurs with higher prevalence in men
with cryptorchidism and KS, if THF represents connective tissue
with vessels rather than proper testicular parenchyma. The higher
prevalence of bTHF in men with KS might be related to the
increased prevalence of vessel abnormalities observed in these
(T€uttelmann et al., 2014). A higher rate of pronounced THF in
men operated for cryptorchidism or having persisting cryp-
torchidism compared to men with milder forms of cryptorchidism
may raise the hypothesis that TM in cryptorchidism is particularly
associated with subgroups with severe cryptorchidism.
Strengths and weaknesses of the study
The patient material was an unselected cohort of consecu-
tively referred, azoospermic men.
As the included azoospermic men were not only examined
clinically and with genetic and endocrinological analyses but the
majority also histologically based on testicular biopsies, it was
possible to compare the ultrasonographic findings with testicu-
lar histology, including malignancy and pre-malignancy. Fur-
thermore, it is a strength that all men were carefully examined
by the same clinician using the same examination program and
a 7.5 MHz linear ultrasound transducer during the entire study.
The weakness of this study is that the program was performed
with the purpose to identify the etiology of the azoospermia and
the treatment possibilities of the couple. Thus, the present
results were not collected from a prospective study with THF
Figure 2 Universally distributed, pronounced THF in a 19-year-old man
with azoospermia and only one detectable testis. Testicular spermatozoa
from minor areas with apparently normal spermatogenesis were cryopre-
served before the man was treated for intratubular germ cell neoplasia.
Figure 3 Patterns of universally distributed, pro-
nounced THF in an azoospermic man, when he
was 42 (A) and 50 years old (B). No malignancy
was detected histologically.
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defined as a specific outcome from the beginning. Nevertheless,
testicular ultrasonography was systematically described for each
testis during the primary examination of all men. Another weak-
ness is that it was not possible to include a series of men with
normal semen quality evaluated using the same THF criteria as a
control group.
Comparison with other studies
Different definitions of THF may complicate comparison of
studies. When comparing studies, it is of central importance that
identical definitions of THF are chosen. The predominant defini-
tion of >5 or ≥5 THF per transducer field is arbitrary. Similar to this
study, Coffey et al. (2007) has classified THF according to: none, a
limited, a scant, a moderate, or too numerous THF to count. Mid-
dleton et al. (2002) distinguished between classic and limited THF,
the classic form representing pronounced THF as described here,
while limited THF rather seems to be identical to bTHF.
The prevalence of THF has been assessed in two large series of
healthy male volunteers recruited from the American and Turk-
ish Army Reserve Officer Training Corps, 17–42 years old. In the
US series, 5.6% of 1504 men showed THF (Peterson et al., 2001)
Table 2 The few azoospermic men with tumors and malignancy. Only the 300 patients having taken a testicular biopsy for histological examination are
included in this table
THF pattern History Diagnosis Treatment Frequency in
the subgroup
Significance level
uTHF (>7 THF elements,
universally distributed)
Only one detectable testis Intratubular germ
cell neoplasia
Cryopreservation
of testicular
spermatozoa
1/6 p = 0.04
Radiation,
16 Gy/8 fractions
Minor foci with
sperm production
pTHF (>7 THF elements,
collected in plaques)
No specific
andrological problems
Intratubular germ
cell neoplasia
Orchiectomy. Ejac.
spermatozoa
one year after op.
1/7 p = 0.05
Klinefelter’s syndrome Sertoli cell –
Leydig cell tumor?
Unilat. Orchiectomy
bTHF (3–7 THF elements) Bilateral cryptorchidism
in childhood (hCG)
Intratubular germ
cell neoplasia
Orchiectomy 1/21 p = 0.14
No THF (<3 THF elements) Anejaculation
following
myelomeningocele
Seminoma Orchiectomy 1/266
(A) (B)Figure 5 Cytokeratin-18 (CK-18), a marker for
Sertoli cell immaturity, detected in the seminif-
erous tubules using a three-stage immunoper-
oxidase technique as described in detail in the
main text. Presence of CK-18 was visualized
using diaminobenzidine tetrahydrochloride
(DAB). (A) A 29-year-old man treated twice with
chemotherapy because of Hodgkin’s disease,
with Sertoli cells in a biopsy, positive for CK-18.
(B) A 36-year-old proven fertile man undergoing
vasectomy, negative for CK-18.
Figure 4 Pronounced THF located in five small plaques in a testis of a 22-
year-old man with azoospermia. Histologically, he had intratubular germ
cell neoplasia.
© 2016 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of
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compared to 2.4% of 2179 men in the Turkish series (Serter et al.,
2006). The prevalence of THF is associated with ethnicity. Thus,
Peterson et al. (2001) found TM in 14.1% black men compared
to 4.2% in white men. The prevalence of THF was 2.4% in a
Dutch study including 694 asymptomatic boys and young men 0
to 19 years old. The prevalence was significantly higher in the
older boys compared to the youngest boys, suggesting that THF
develops during childhood and puberty (Goede et al., 2009).
Several studies have demonstrated or suggested an association
between THF and pathological andrological conditions such as KS
(Martinez-Valls et al., 2003 & Fedder et al., 2015), cryptorchidism
(Nistal et al., 1979; Riebel et al., 2000 & Goede et al., 2010), and
infertility (von Eckardstein et al., 2001 & Aizenstein et al., 1998).
THF has been found strongly associated with the development of
TGCN. In a metaanalysis including 33 papers, Tan et al. (2010)
found a pooled risk ratio for concurrent TGCN of 8.5 (95% CI: 4.5–
16.1) in the presence of THF in men with risk factors for TGCN.
The pooled risk ratio for IGCN seems similar to the pooled risk
ratio for TGCN (Tan et al., 2010), while the risk for TGCN and
IGCN seems very low in adult asymptomatic men with THF but
without risk factors (Peterson et al., 2001 & Serter et al., 2006). No
clinical sign of testicular malignancy was observed in those 3683
men. Furthermore, 63 of 84 men with THF in the US study were
included in a 5-year follow-up study, and only one man developed
malignancy. Thus, a mixed germ cell tumor developed 64 months
after the initial screening study (DeCastro et al., 2008). Therefore,
THF is suggested not to be an etiological factor in TGCN – but
rather a marker or a familial risk factor increasing the risk of
TGCN (Coffey et al., 2007) particularly in men with other risk
factors, for example cryptorchidism (Goede et al., 2010).
A positive point is that the majority of men with THF will
never develop testicular cancer.
Therefore, an important question is how men with THF
should be controlled and treated, depending on the presence of
concomitant TGCN risk factors. When developing a ‘cost-effec-
tive’ follow-up program, it might be useful to distinguish between
different THF patterns categorized as demonstrated in this study.
The cause–effect relations between THF and andrological con-
ditions, including neoplasia, are not clearly highlighted. Coffey
et al. (2007) found THF aggregated in families, not only in men
with testicular neoplasia but also in unaffected male relatives.
On this background, they suggest a common genetic susceptibil-
ity to THF and testicular neoplasia rather than considering THF
as etiological factor for neoplasia.
Even though a high prevalence of THF is found in men with
KS, these men usually have only few THF (Fedder et al., 2015),
denominated as bTHF in this paper and discussed previously,
and the incidence of testicular cancer in KS men is not higher
than in other men (Hasle et al., 1995 & Swerdlow et al., 2005).
The cytoskeleton is composed of intermediate filaments,
microfilaments, and microtubules. The intermediate filaments
can be subdivided into six families, including the keratins
described here and vimentin, which is the intermediate filament
characteristic for normal adult Sertoli cells (Aum€uller et al.,
1992). In this study, we were able to detect CK-18 in ~50% (10 of
21) of azoospermic men with impaired spermatogenesis, and
without THF and TM, but only in two of 19 men with near nor-
mal spermatogenesis, showing that expression of CK-18 in the
Sertoli cells not necessarily cause THF. The mechanisms behind
THF and TMmay be complex.
In this study, remarkably high numbers of patients with uTHF
and bTHF not only had a histological pattern with atrophy of the
seminiferous tubules but also foci with production of spermato-
zoa or spermatids. It is exactly such azoospermic men with
mixed testicular atrophy who show Sertoli cell immaturity
demonstrated by expression of antim€ullerian hormone (AMH)
and cytokeratin-18 (CK-18) in their adult Sertoli cells (Maymon
et al., 2000, 2002). Our data support that CK-18 is more fre-
quently expressed in testicles of men with mixed testicular atro-
phy. However, as none of the 33 azoospermic men examined for
CK-18 showed THF or TM, CK-18 expression in Sertoli cells may
be more frequent than presence of THF and TM.
CONCLUSIONS AND FUTURE RESEARCH
A total prevalence of THF, pronounced or borderline, was ret-
rospectively found in 13.4% and pronounced in 5% of 382 unse-
lected, non-vasectomized, azoospermic men. The relatively high
frequency of bilateral uTHF and bTHF support the hypothesis of
a general defective spermatogenesis as background of THF. THF
seems more frequent than TM, and THF not necessarily repre-
sents TM.
The 19-year-old, azoospermic man, who had cryopreserved
testicular spermatozoa from his one and only testis, illustrates
the importance of alertness to cryopreservation of spermatozoa
before treatment for GCN. In similar cases, it may be recom-
mended to collaborate with a fertility clinic to optimize the abil-
ity of the patients to reproduce in later life. If the testis was
primarily exposed to radiation, the fertility potential of this man
would have been reduced to zero.
Several questions remain to be answered regarding a possi-
ble relationship between THF and reduced spermatogenesis as
found in KS and cryptorchidism and the association between
THF and testicular malignancy. When comparing studies, con-
sensus according to definition of THF is a must. The com-
monly used limit of five THF in one transducer field is
arbitrarily chosen. Ideally, all THF elements should be identi-
fied, localized, and counted, and the THF status of each testi-
cle related to spermatogenesis, (pre-)malignancy and etiology,
and based on analysis of huge materials, a useful THF defini-
tion should be established. In addition to number and localiza-
tion, attention may be given to each THF element. Thus, we
have observed some more matte, grayish elements. Further-
more, larger prospective studies are needed to explain the
mechanisms behind THF and to evaluate the predictive value
of categories of THF for the presence of TGCN and IGCN in
more details. Possible associations between testicular hypere-
chogenic loci and microlithiasis may be highlighted in animal
studies.
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